Tower Research Capital LLC (Trc) Savara Inc Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Savara Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,281 shares of SVRA stock, worth $10,499. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,281

Previous 14,769 77.78%

Holding current value

$10,499

Previous $59,000 77.97%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.96 - $5.07 $45,492 - $58,244	-11,488 Reduced 77.78%	3,281 $13,000
Q2 2024 Aug 13, 2024	BUY	$3.66 - $5.34 $46,214 - $67,428	12,627 Added 589.5%	14,769 $59,000
Q1 2024 May 15, 2024	SELL	$4.19 - $5.59 $72,759 - $97,070	-17,365 Reduced 89.02%	2,142 $10,000
Q4 2023 Feb 13, 2024	BUY	$3.18 - $4.9 $53,929 - $83,099	16,959 Added 665.58%	19,507 $91,000
Q3 2023 Nov 14, 2023	SELL	$2.97 - $3.88 $18,125 - $23,679	-6,103 Reduced 70.55%	2,548 $9,000
Q2 2023 Aug 14, 2023	SELL	$1.69 - $3.24 $5,387 - $10,329	-3,188 Reduced 26.93%	8,651 $27,000
Q1 2023 May 09, 2023	SELL	$1.6 - $2.82 $26,806 - $47,246	-16,754 Reduced 58.59%	11,839 $23,000
Q4 2022 Feb 10, 2023	BUY	$1.11 - $1.64 $11,910 - $17,597	10,730 Added 60.07%	28,593 $44,000
Q3 2022 Nov 10, 2022	BUY	$1.36 - $1.88 $2,320 - $3,207	1,706 Added 10.56%	17,863 $28,000
Q2 2022 Aug 15, 2022	BUY	$1.1 - $1.58 $17,772 - $25,528	16,157 New	16,157 $25,000
Q1 2022 May 12, 2022	SELL	$1.05 - $1.36 $105 - $136	-100 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.04 - $1.34 $24,292 - $31,299	-23,358 Reduced 99.57%	100 $0
Q3 2021 Nov 15, 2021	BUY	$1.18 - $1.64 $1,276 - $1,774	1,082 Added 4.84%	23,458 $32,000
Q2 2021 Aug 16, 2021	BUY	$1.51 - $2.29 $15,201 - $23,053	10,067 Added 81.79%	22,376 $38,000
Q1 2021 May 17, 2021	SELL	$1.17 - $2.33 $8,308 - $16,545	-7,101 Reduced 36.58%	12,309 $25,000
Q4 2020 Feb 16, 2021	SELL	$1.0 - $1.47 $34,133 - $50,175	-34,133 Reduced 63.75%	19,410 $22,000
Q3 2020 Nov 16, 2020	BUY	$1.09 - $2.21 $49,458 - $100,278	45,375 Added 555.52%	53,543 $58,000
Q2 2020 Aug 13, 2020	BUY	$1.8 - $3.05 $8,704 - $14,749	4,836 Added 145.14%	8,168 $20,000
Q1 2020 May 15, 2020	SELL	$1.91 - $4.08 $10,325 - $22,056	-5,406 Reduced 61.87%	3,332 $7,000
Q4 2019 Feb 07, 2020	BUY	$0.71 - $4.91 $6,203 - $42,903	8,738 New	8,738 $39,000
Q3 2019 Nov 05, 2019	SELL	$2.16 - $3.2 $1,468 - $2,176	-680 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$2.37 - $11.7 $17,481 - $86,299	-7,376 Reduced 91.56%	680 $2,000
Q1 2019 May 14, 2019	SELL	$6.71 - $8.6 $11,292 - $14,473	-1,683 Reduced 17.28%	8,056 $59,000
Q4 2018 Feb 14, 2019	BUY	$6.27 - $10.92 $58,555 - $101,981	9,339 Added 2334.75%	9,739 $73,000
Q3 2018 Nov 13, 2018	BUY	$10.49 - $12.87 $4,196 - $5,148	400 New	400 $4,000
Q1 2018 May 15, 2018	SELL	$8.99 - $14.95 $323 - $538	-36 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$8.26 - $16.76 $297 - $603	36	36 $1,000

Others Institutions Holding SVRA

# of Institutions

128

Shares Held

158M

Call Options Held

67.6K

Put Options Held

29.4K

View Full List

About Savara Inc

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $365M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

More about SVRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Savara Inc Transaction History